Elevation Wealth Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$245K Buy
2,873
+425
+17% +$38.5K 0.07% 126
2026
Q2
$224K Buy
2,448
+457
+23% +$40K 0.07% 127
2026
Q1
$170K Sell
1,991
-166
-8% -$14.8K 0.06% 126
2025
Q4
$170K Buy
2,157
+225
+12% +$17.6K 0.06% 127
2025
Q3
$154K Sell
1,932
-648
-25% -$55.3K 0.06% 136
2025
Q2
$235K Hold
2,580
– – 0.09% 103
2025
Q1
$242K Hold
2,580
– – 0.1% 100
2024
Q4
$235K Hold
2,580
– – 0.1% 104
2024
Q3
$268K Hold
2,580
– – 0.12% 96
2024
Q2
$250K Sell
2,580
-500
-16% -$46.1K 0.12% 96
2024
Q1
$277K Hold
3,080
– – 0.14% 93
2023
Q4
$219K Buy
+3,080
New +$232K 0.13% 93
2023
Q3
– Hold
0
– – – 342
2023
Q2
– Hold
0
– – – 351

Other funds holding CL

Elevation Wealth Partners's CL Position: Q3 2026 in Review

Elevation Wealth Partners increased its Colgate-Palmolive (CL) stake by 17% in Q3 2026, buying an estimated $38.5K and bringing the position to 2,873 shares worth $245K. The position accounts for 0.07% of the portfolio, ranked #126.

Elevation Wealth Partners first reported a position in CL in Q4 2023 and has held it in 12 quarters since. The position peaked at $277K in Q1 2024. 667 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Elevation Wealth Partners held 2,873 shares of Colgate-Palmolive worth $245K as of Q3 2026.
  • Elevation Wealth Partners bought 425 Colgate-Palmolive shares in Q3 2026, an estimated $38.5K.
  • Colgate-Palmolive made up 0.07% of Elevation Wealth Partners's portfolio in Q3 2026, its #126 holding.
  • Elevation Wealth Partners first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 12 quarters since.
  • Elevation Wealth Partners's Colgate-Palmolive position peaked at $277K in Q1 2024.
  • 667 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.